Orphenadrine
DrugBank ID: DB01173
Summary
| Metric | Value |
|---|---|
| Total Predictions | 50 |
| KG+DL (Dual Validated) | 0 |
| DL Only | 50 |
| KG Only | 0 |
Predictions
| Indication | Score | Source |
|---|---|---|
| retinal dystrophy with or without extraocular anomalies | 0.9929 | DL |
| congenital disorder of glycosylation with defective fucosylation | 0.9927 | DL |
| polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis | 0.9921 | DL |
| Charcot-Marie-Tooth disease, demyelinating, type 1G | 0.9919 | DL |
| schizophrenia | 0.9913 | DL |
| Parkinson disease | 0.9911 | DL |
| myopia X-linked | 0.9909 | DL |
| myopia 26, X-linked, female-limited | 0.9900 | DL |
| syndromic myopia | 0.9897 | DL |
| atypical glycine encephalopathy | 0.9895 | DL |
| hydranencephaly (disease) | 0.9895 | DL |
| paralysis agitans, juvenile, of Hunt | 0.9888 | DL |
| lethal infantile mitochondrial myopathy | 0.9860 | DL |
| PLA2G6-associated neurodegeneration | 0.9831 | DL |
| parkinsonian disorder | 0.9809 | DL |
| hereditary late onset Parkinson disease | 0.9737 | DL |
| X-linked parkinsonism-spasticity syndrome | 0.9661 | DL |
| Lewy body dementia | 0.9516 | DL |
| progressive supranuclear palsy-corticobasal syndrome | 0.9480 | DL |
| atypical juvenile parkinsonism | 0.9464 | DL |
| hemiparkinsonism-hemiatrophy syndrome | 0.9343 | DL |
| autosomal recessive Parkinson disease | 0.9318 | DL |
| schizophreniform disorder | 0.9188 | DL |
| juvenile onset Parkinson disease 19A | 0.9185 | DL |
| myelitis | 0.9150 | DL |
| Rasmussen subacute encephalitis | 0.9127 | DL |
| early-onset parkinsonism-intellectual disability syndrome | 0.9092 | DL |
| parkinsonian-pyramidal syndrome | 0.8989 | DL |
| psychotic disorder | 0.8981 | DL |
| transaldolase deficiency | 0.8966 | DL |
| X-linked spasticity-intellectual disability-epilepsy syndrome | 0.8916 | DL |
| fructose-1,6-bisphosphatase deficiency | 0.8842 | DL |
| X-linked intellectual disability-ataxia-apraxia syndrome | 0.8800 | DL |
| early-onset schizophrenia | 0.8647 | DL |
| X-linked intellectual disability-cerebellar hypoplasia syndrome | 0.8647 | DL |
| CLCN4-related X-linked intellectual disability syndrome | 0.8608 | DL |
| attention deficit-hyperactivity disorder | 0.8606 | DL |
| dystonia | 0.8573 | DL |
| X-linked intellectual disability-spastic quadriparesis syndrome | 0.8533 | DL |
| X-linked intellectual disability-precocious puberty-obesity syndrome | 0.8528 | DL |
| NAA10-related syndrome | 0.8509 | DL |
| MED12-related intellectual disability syndrome | 0.8491 | DL |
| syndromic X-linked intellectual disability Chudley-Schwartz type | 0.8477 | DL |
| X-linked cerebral-cerebellar-coloboma syndrome syndrome | 0.8471 | DL |
| treatment-refractory schizophrenia | 0.8466 | DL |
| intellectual disability, X-linked, syndromic | 0.8465 | DL |
| Prieto syndrome | 0.8455 | DL |
| Paganini-Miozzo syndrome | 0.8440 | DL |
| hydrocephaly-cerebellar agenesis syndrome | 0.8437 | DL |
| X-linked intellectual disability-hypotonia-movement disorder syndrome | 0.8437 | DL |
External Links
Disclaimer
Predictions are for research purposes only and do not constitute medical advice.
Predictions are for research purposes only and do not constitute medical advice.